The Role of Protease-Activated Receptor 2 in Hepatocellular Carcinoma after Hepatectomy

Background and Objectives: Protease activated receptor-2 (PAR2) is elevated in a variety of cancers and has been promoted as a potential therapeutic target. However, the clinical and prognostic values of PAR2 in hepatocellular carcinoma (HCC) are poorly characterized. This study aimed to evaluate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Ming-Chao, Lin, Chih-Che, Chen, Ding-Wei, Liu, Yueh-Wei, Wu, Yi-Ju, Yen, Yi-Hao, Huang, Pao-Yuan, Yao, Chih-Chien, Chuang, Ching-Hui, Hsiao, Chang-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229727/
https://www.ncbi.nlm.nih.gov/pubmed/34199695
http://dx.doi.org/10.3390/medicina57060574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229727/
https://www.ncbi.nlm.nih.gov/pubmed/34199695
http://dx.doi.org/10.3390/medicina57060574

Ejemplares similares